Redox Biology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2024-12-11 sucao 来自湖南省

没有想象中的容易，wang hong编辑，两个工作日拒稿

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2024-12-01 大卫营来自安徽省

偏重的研究方向：炎症
经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路

10 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2023-08-18 ms8000000123523430 来自安徽省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：氧化应激;肾损伤
经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。

113 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2024-11-10 ms5000000872293535 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：乳酸化;心血管
经验分享：11.04号 submit to journal
11.10号 under review。 Review invitations sent 6个

16 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2024-11-21 格鲁鲁来自江苏省

请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2024-11-06 ms4000000265024223 来自山东省

偏重的研究方向：mitophagy;肿瘤;ROS
经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2024-10-12 1522336 来自重庆

9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2024-01-14 Drforebo 来自陕西省

审稿速度:1.0
经验分享：重新更新一下
11.8 submitted to journal
11.12 under review
11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。
一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。
非常感谢编辑Hong Wang教授和各位审稿专家的贡献。

4 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2022-11-23 ms5000001831460627 来自维多利亚

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：ROS;Redox signaling
经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。

139 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241806, encodeId=34be2241806a4, content=没有想象中的容易，wang hong编辑，两个工作日拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=sucao, createdTime=Wed Dec 11 11:23:35 CST 2024, time=2024-12-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2240263, encodeId=27d1224026313, content=偏重的研究方向：炎症 经验分享：11.5投稿 11.6送审 11.7一个审稿人接受审稿，11.9一个审稿人接受审稿，11.20一个审稿人完成审稿，现在另外一个审稿人迟迟没有消息，这个杂志审稿一般要求多久内完成啊，好担心审稿人跑路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/08/72908a7dfd4ac061280c109b6f2ed19c.jpg, createdBy=18195261992, createdName=大卫营, createdTime=Sun Dec 01 17:32:06 CST 2024, time=2024-12-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2153387, encodeId=430e215338eff, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：氧化应激;肾损伤 经验分享：外审差不多两个月，其中一个审稿人一直没审回来，加送审稿人，小修10天后再次送审，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d89c8186934, createdName=ms8000000123523430, createdTime=Fri Aug 18 11:19:48 CST 2023, time=2023-08-18, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2236232, encodeId=432822362325e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳酸化;心血管 经验分享：11.04号 submit to journal 11.10号 under review。 Review invitations sent 6个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad75438566, createdName=ms5000000872293535, createdTime=Sun Nov 10 21:05:47 CST 2024, time=2024-11-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2238144, encodeId=22112238144b0, content=请问期刊收什么样水平的文章，属于小一区的水平，还是小子刊水平？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03905514842, createdName=格鲁鲁, createdTime=Thu Nov 21 12:52:03 CST 2024, time=2024-11-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2235552, encodeId=bd2a223555229, content=偏重的研究方向：mitophagy;肿瘤;ROS 经验分享：with editor 4天后显示 Transfer Pending，一般来说有必要转投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Wed Nov 06 21:12:02 CST 2024, time=2024-11-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2230566, encodeId=0f232230566a3, content=9.19投 9.20送审 9.25 10.3 10.9 更新了三次都是under review 是不是找不到审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Sat Oct 12 22:13:09 CST 2024, time=2024-10-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181558, encodeId=2264218155845, content=审稿速度:1.0 经验分享：重新更新一下 11.8 submitted to journal 11.12 under review 11.30 reject，编辑给了resubmission的机会，应该是大修，编辑在决定信里明确说明本期刊没有大修选项。两个审稿人意见提了三十多个问题，偏正向，需要补部分实验。 一个月后重投，五天后under review，其中有一个审稿人是新邀请的，审稿周期12天，小修，二号同意接受，一号指出若干句子存在语法问题，当天润色后返修。编辑再次送外审并邀请了新的审稿人。四天后accept，前后一共四个审稿人。 非常感谢编辑Hong Wang教授和各位审稿专家的贡献。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7eb5466518, createdName=Drforebo, createdTime=Sun Jan 14 14:45:42 CST 2024, time=2024-01-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2102318, encodeId=9b4d2102318e5, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：ROS;Redox signaling 经验分享：九月底投稿，两天送审，三周返回审稿意见，两个reviewer都推荐发表，编辑给了两周小修，为了回答一个reviewer加了实验所以延了一点，两周半提交小修版本，上午提交，当天晚上接收。整个流程两个月不到，非常效率。其实感觉可以不加那个实验也可以接收，可以更快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93358446372, createdName=ms5000001831460627, createdTime=Wed Nov 23 22:27:56 CST 2022, time=2022-11-23, status=1, ipAttribution=维多利亚), GetPortalCommentsPageByObjectIdResponse(id=2206367, encodeId=5f4c220636e1b, content=偏重的研究方向：Toxicology;ROS 经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48e66163004, createdName=ms3000001959777411, createdTime=Fri May 24 09:14:58 CST 2024, time=2024-05-24, status=1, ipAttribution=江苏省)]

2024-05-24 ms3000001959777411 来自江苏省

偏重的研究方向：Toxicology;ROS
经验分享：无语了，5.9中午12：50投出去的，到现在还是with editor，你们说的效率是认真的么

101 9

展开9条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务